Opinion|Videos|August 27, 2025
Unmet Needs for the Management of Alopecia Areata
Key Takeaways
- Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles.
- Breakdown of immune privilege in hair follicles leads to infiltration by cytotoxic T cells, particularly CD8+ T cells.
Panelists discuss how switching therapies in patients with alopecia areata (AA) is often necessary when initial treatments fail, though it can create a cost burden, and how beyond updated guidelines, there are unmet needs such as improved long-term treatments and better psychological support for patients.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Mostaghimi: What is your approach to switching therapies in patients with AA?
- Discuss how switching therapies can be a cost burden for patients.
- Friedland: Beyond updated guidelines for AA, what are some other unmet needs for the management of this disease?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
ATTR-CM Incidence, Prevalence Rose Sharply in the US
2
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
3
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
4
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
5